Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis
22:28 EDT 29 Aug 2012 | The Medical News
Protalex, Inc., a clinical stage biopharmaceutical company focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including rheumatoid arthritis (RA), today announced results from its recently completed..
Original Article: Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis
More From BioPortfolio on "Protalex announces results from PRTX-100 Phase 1b trial on active rheumatoid arthritis"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
